Finance

Lists
Outlook: 13.0% bullish·56.5% bearish
Go to analysis
LQDA:NASDAQ
Liquidia Corp
$25.76
-0.56%
(-0.15) 1D
Oct 7, 2:16:20 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LQDA...
Open
$25.55
High
$26.99
Low
$24.59
Mkt. cap
2.31B
Avg. vol.
3.18M
Volume
3.95M
P/E ratio
18.59
52-wk high
$93.61
52-wk low
$21.94
EPS
$1.39
Beta
0.61
Shares outstanding
89.51M
No. of employees
216
Open
$25.55
High
$26.99
Low
$24.59
Mkt. cap
2.31B
Avg. vol.
3.18M
Volume
3.95M
P/E ratio
18.59
52-wk high
$93.61
52-wk low
$21.94
EPS
$1.39
Beta
0.61
Shares outstanding
89.51M
No. of employees
216
News stories
From web sources and news partners
About Liquidia Corp
CEO-
Employees216
Founded2004
HeadquartersMorrisville, North Carolina, United States
SectorPharmaceutical industry
Websiteliquidia.com
Analyst ratings
Based on 8 analysts giving stock ratings to LQDA in the past 3 months
Buy
Buy
4
Hold
4
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for LQDA in the last 3 months.
Highest
Current $25.76
$72.00 (+179.45%)
Average
$51.60 (+100.27%)
Lowest
$30.00 (+16.44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Amy Li
Jefferies
Buy
Maintained
$45.00
+74.7%
10/05/2026
Andrew Fein
H.C. Wainwright
Buy
Reiterated
$58.00
+125.1%
10/02/2026
Benjamin Burnett
Wells Fargo
Hold
Downgraded
$30.00
+16.4%
10/01/2026
Jason Gerberry
Bank of America Securities
Hold
Maintained
-
-
10/01/2026
Julian Harrison
BTIG
Hold
Downgraded
-
-
10/01/2026
Gaurav Maini
LifeSci Capital
Hold
Reiterated
-
-
09/30/2026
Serge Belanger
Needham
Buy
Maintained
$72.00
+179.4%
09/30/2026
Ryan Deschner
Raymond James
Buy
Maintained
$53.00
+105.7%
10/01/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$51.00
+97.9%
04/01/2026
Andreas Argyrides
Oppenheimer
Sell
Maintained
$19.00
-26.3%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
54.34M
92.02M
132.86M
171.68M
Cost of goods sold
3.17M
7.06M
11.85M
11.55M
Cost of revenue
3.17M
7.06M
11.85M
11.55M
Research and development expenses
9.35M
16.94M
12.22M
17.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.06M
48.24M
47.29M
57.43M
Operating expense
49.40M
65.18M
59.51M
74.61M
Total operating expenses
52.58M
72.23M
71.36M
86.16M
Operating income
1.77M
19.79M
61.50M
85.52M
Other non operating income
-
-
-
-
EBT including unusual items
-3.53M
14.56M
56.78M
81.70M
EBT excluding unusual items
-3.53M
14.56M
56.78M
81.70M
Income tax expense
-
-
3.92M
6.98M
Effective tax rate
-
-
6.90%
8.54%
Other operating expenses
-
-
-
-
Net income
-3.53M
14.56M
52.86M
74.72M
Net profit margin
-6.50%
15.82%
39.79%
43.52%
Earnings per share
-0.04
0.15
0.52
0.74
Interest and investment income
1.64M
1.67M
1.77M
2.48M
Interest expense
-6.94M
-6.90M
-6.49M
-6.30M
Net interest expenses
-5.30M
-5.23M
-4.72M
-3.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.04M
20.01M
61.90M
85.82M
Gain or loss from assets sale
-
11.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps